title: Indirect methods for the diagnosis of aluminum bone disease: plasma aluminum, the desferrioxamine infusion test, and serum iPTH.
authors.forename: H G
authors.initials: HG
authors.lastname: Nebeker
authors.forename: D L
authors.initials: DL
authors.lastname: Andress
authors.forename: D S
authors.initials: DS
authors.lastname: Milliner
authors.forename: S M
authors.initials: SM
authors.lastname: Ott
authors.forename: A C
authors.initials: AC
authors.lastname: Alfrey
authors.forename: E A
authors.initials: EA
authors.lastname: Slatopolsky
authors.forename: D J
authors.initials: DJ
authors.lastname: Sherrard
authors.forename: J W
authors.initials: JW
authors.lastname: Coburn
mesh_terms: D000535:Aluminum / Q000009:adverse effects* / Q000097:blood; D003676:Deferoxamine; D006801:Humans; D007676:Kidney Failure, Chronic / Q000628:therapy; D010018:Osteomalacia / Q000139:chemically induced / Q000175:diagnosis*; D010281:Parathyroid Hormone / Q000097:blood; D006435:Renal Dialysis / Q000009:adverse effects*
chemical_list: D010281:Parathyroid Hormone; D000535:Aluminum; D003676:Deferoxamine